We are live on ! Find out more
USNA icon

Usana Health Sciences

188 hedge funds and large institutions have $1.19B invested in Usana Health Sciences in 2019 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 71 increasing their positions, 54 reducing their positions, and 38 closing their positions.

New
Increased
Maintained
Reduced
Closed

148% more capital inflows, than outflows

Capital inflows: $271M | Capital outflows: $109M

31% more repeat investments, than reductions

Existing positions increased: 71 | Existing positions reduced: 54

30% more call options, than puts

Call options by funds: $1.32M | Put options by funds: $1.02M

9.41% more ownership

Funds ownership: 51.59% → 61% (+9.4%)

1% less funds holding

Funds holding: 189 → 188 (-1)

5% less first-time investments, than exits

New positions opened: 36 | Existing positions closed: 38

100% less funds holding in top 10

Funds holding in top 10: 3 → 0 (-3)

Holders
188
Holders Change
-1
Holders Change %
-0.53%
% of All Funds
4.06%
Holding in Top 10
–
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-100%
% of All Funds
–
New
36
Increased
71
Reduced
54
Closed
38
Calls
$1.32​M
Puts
$1.02​M
Net Calls
+$304​K
Net Calls Change
+$2.66​M

USNA Hedge Fund Activity: Q1 2019 in Review

188 of the 4,633 institutional investors tracked by Wall St. Rank reported a position in Usana Health Sciences (USNA) for Q1 2019, worth a combined $1.19B — down 18% from $1.46B a quarter earlier.

Sellers outnumbered buyers: 38 funds closed out of USNA and 36 opened new positions — a net loss of 2 holders — while 54 trimmed existing stakes and 71 added.

The largest buyer was Morgan Stanley, adding an estimated $28.2M. The largest seller was TIAA CREF Investment Management, cutting an estimated $16.8M.

  • 188 institutional investors held Usana Health Sciences (USNA) as of Q1 2019, down from 189 in Q4 2018.
  • Funds reported $1.19B of Usana Health Sciences stock for Q1 2019, down 18% quarter-over-quarter.
  • 36 funds opened new Usana Health Sciences positions in Q1 2019 and 38 closed out, a net change of -2 holders.
  • The largest Usana Health Sciences buyer in Q1 2019 was Morgan Stanley, an estimated $28.2M added.
  • The largest Usana Health Sciences seller in Q1 2019 was TIAA CREF Investment Management, an estimated $16.8M sold.

Based on aggregated 13F filings for Q1 2019.